Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

SHE:002773 Revenue

Chengdu Kanghong Pharmaceutical Group had revenue of 1.13B CNY in the quarter ending June 30, 2026, a decrease of -9.74%. This brings the company's revenue in the last twelve months to 4.31B, down -6.54% year-over-year. In the year 2025, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.59B with 2.98% growth.

• Revenue (ttm): 4.31B
• Revenue Growth: -6.54%
• P/S Ratio: 4.45
• Revenue / Employee: 964.35K
• Employees: 4,470
• Market Cap: 19.17B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.59B	132.48M	2.98%
Dec 31, 2024	4.45B	495.20M	12.51%
Dec 31, 2023	3.96B	568.43M	16.77%
Jan 1, 2023	3.39B	-216.32M	-6.00%
Jan 1, 2022	3.61B	309.92M	9.40%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error